News

Are Peptides Legal in India? 2026 Regulatory Gu...

A clear, India-specific 2026 explainer on the regulatory status of research peptides. Covers CDSCO, FSSAI, the Drugs and Cosmetics Act 1940, the Drugs and Magic Remedies Act 1954, the FSSA...

GHK-Cu in India: Complete 2026 Buyer's Guide (P...

Everything India researchers need to know about buying GHK-Cu (copper tripeptide) in 2026 — price benchmarks, purity standards, vendor red flags, and what differentiates research-grade lyophilised vials from cosmetic copper-peptide...

TB-500 vs BPC-157: Which Healing Peptide Should...

BPC-157 and TB-500 are the two most-cited "healing peptides" in modern research literature — frequently studied together but biochemically very different. Here's a side-by-side comparison for India researchers in 2026,...

BPC-157 India: Research Peptide Guide, Dosage R...

BPC-157 is the most-cited healing peptide in modern research literature. This India-focused 2026 guide covers what BPC-157 actually is, fair INR pricing, dosage reference ranges used in research protocols, vendor...

Retatrutide in India: 2026 Price Guide, Legal S...

Retatrutide (LY-3437943) — the first widely-studied GIP/GLP-1/glucagon triple-receptor agonist — is the most-searched new-generation peptide of 2026. Here's the India-specific buyer's guide: price benchmarks in INR, vendor red flags, legal...